Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

---

Summary

• President's Associate Presidential Professor
• Director, PGY2 Pediatric Pharmacy Residency
• Director, Pediatric Pharmacotherapy Degree Option

---

Publications & Presentations

41. Fox A, Nation B E, Autry M, Johnson P N. Possible role for acetylcysteine as a treatment for acute liver failure secondary to antitubercular medication use. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2020; 77 : 1482-1487

42. Cox C L, Todd T J, Lubsch L, Klein K C, Prescott, Jr W A, Knoderer C A, Johnson P N, Meyers R, Cole J W, LaRochelle J M, K S. Joint Statement on Pediatric Education at Schools of Pharmacy. American journal of pharmaceutical education. 2020; 84 : ajpe7892

43. Johnson P N. Pain management. American College of Clinical Pharmacy. 2020 : 900-943

44. Harkin M, Shaddix B P, Neely S, Peek L A, Stephens K, Barker P, McMullan L, Gormley A, Johnson P N. Evaluation of dosing and safety outcomes of low-dose prophylactic warfarin in children after cardiothoracic surgery. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2020; 77 : 1018-1025

45. Nguyen T T, Bergeron E, Lewis T V, Miller J L, Hagemann T M, Neely S, Johnson P N. Descriptive study of discharge medications in pediatric patients. SAGE open medicine. 2020; 8 : 2050312120927945

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Dom Ropp). Date: 2023.


2. Oklahoma Society of Health-System Pharmacists/Oklahoma Pharmacy Residency Research Conference. Oklahoma Residency Research Excellence Award (served as mentor for Eugenie Chang). Date: 2023.


3. University of Oklahoma College of Medicine--Department of Pediatrics. Mentor award (for Caitlyn Bradford, PharmD). Date: 2022.


4. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2019.


5. Pediatric Pharmacy Advocacy Group. Christensen Young Investigator Award (Served as resident mentor). Date: 2016.

Education

1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.


2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.


3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.


4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.

Administrative Assignments

no results